Are Bogsnes
Papers
3
Total Citations
42
H-Index
3
About
Are Bogsnes is a researcher specializing in bioprocessing and downstream process development, with a particular focus on the purification and separation of cell-based products. Their work sits at the critical interface between fundamental biological research and clinical translation, addressing one of the most pressing challenges in cell therapy development: the scalable, cost-effective isolation of therapeutic cells. Bogsnes has made significant contributions to advancing aqueous two-phase systems (ATPS) as a practical platform for cell purification. These systems offer a compelling alternative to conventional separation methods by enabling label-free, gentle, and scalable processing — qualities essential for maintaining cell viability and function in clinical applications. Their 2016 high-throughput downstream processing study, which has garnered 26 citations, established a foundational framework for applying ATPS in cell-based product manufacturing. Subsequent work explored how polymer molecular weight and tie-line length influence the resolution of distinct cell lines, further refining the scientific understanding of ATPS performance parameters. Collectively, Bogsnes' research has helped bridge the gap between laboratory-scale innovation and clinical-scale implementation, offering the field of regenerative medicine and cell therapy more reliable and accessible purification strategies. Their body of work continues to inform efforts to bring cell-based therapies closer to widespread clinical use.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3